QUATTROMED Ltd. - SPIN OFF COMPANY OF THE TARTU UNIVERSITY - FROM THE ACADEMIC LAB TO THE INTERNATIONAL MARKET
Erki Mцlder, CEO and Tiit Talpsep, CTO
Quattromed Ltd., Nooruse Street 9, 50411 Tartu, ESTONIA
www.quattromed.com; Tel. 372 7 380 276; e-mail: quattromed@quattromed.ee
Quattromed has :
- founded as a spin off company of the University of Tartu in 1999.
- based on Estonian and Finnish private capital
- 22 employees
- diversified portfolio of products and services
- unique business model - no VC, investments into R&D are coming from sales (cash-flow)
Quattromed provides:
- molecular diagnostic services - Estonian market (70% market share)
- tools for functional genomics and functional proteomics - US and European market
- services to academic and commercial R&D laboratories - European market
- know-how - European market
- Molecular diagnostic services - Quattromed offers in-house PCR diagnostic services for detection and subtyping of pathogenic microorganisms: Chlamydia trachomatis; Neisseria gonorrhoeae; Mycoplasma hominis; Mycoplasma genitalium; Ureaplasma urealyticum; Ureaplasma parvum; Human papillomavirus; Herpes Simplex virus; Mycoplasma pneumoniae; Chlamydia pneumoniae; Varicella zoster virus; Borrelia burgdorferi; Mycobacterium tuberculosis; Enteroviruses; Hepatitis C virus; Hepatitis B virus. Quattromed has 70% of Estonian market share.
- Tools for functional genomics and functional proteomics - Quattromed has patented E2Tag-technology for labeling, detection and purification of proteins. Quattromed offers cloning and expression vectors, antibodies and molecular tool kits for protein studies, including the tools and kits for studying DNA-protein, RNA-protein and protein-protein interactions. Quattromed provides these products to the end users (scientists) directly and/or through European distribution network. Quattromed products are included into the catalogs and provided worldwide by Fermentas (Lithuania) and Abcam (Great Britain). E2Tag technology is an excellent basement to develop High Throughput Screening Systems.
- Services - Quattromed offers the following services: gene cloning, gene expression studies, protein expression studies, protein expression and purification, development of poly- and monoclonal antibodies, construction of recombinant Baculoviruses for protein production, construction of recombinant Adenoviruses and recombinant Semliki Forest Viruses as gene transfer vechicles, development of stable cell lines expressing the gene of interest.
- Know-how - Quattromed is an excellent SME-type partner for scientific consortiums financed by EC grants, for pharmaceutical companies developing new drugs and for companies developing new biotech- and medical equipment.
Business model - from research and development to the market and from market to the research and development.
Marketing model - tell what are your problems and Quattromed can help.